NENCINI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.603
EU - Europa 1.330
AS - Asia 299
AF - Africa 6
Totale 3.238
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.595
PL - Polonia 438
RU - Federazione Russa 435
IT - Italia 149
IE - Irlanda 107
SE - Svezia 102
SG - Singapore 89
HK - Hong Kong 71
CN - Cina 66
JO - Giordania 33
GB - Regno Unito 30
FI - Finlandia 26
IN - India 22
DE - Germania 12
BE - Belgio 11
TR - Turchia 9
CA - Canada 8
VN - Vietnam 7
CH - Svizzera 6
CI - Costa d'Avorio 6
UA - Ucraina 5
FR - Francia 3
ES - Italia 2
LV - Lettonia 2
CZ - Repubblica Ceca 1
GE - Georgia 1
RO - Romania 1
TW - Taiwan 1
Totale 3.238
Salva come PNG Salva come JPEG
Città #
Warsaw 438
Santa Clara 260
Fairfield 175
Chandler 136
Ashburn 122
Dublin 107
Woodbridge 84
Cambridge 82
Singapore 74
Ann Arbor 73
Houston 69
Seattle 67
Wilmington 64
Hong Kong 48
Lawrence 37
Altamura 35
Beijing 34
Princeton 29
Buffalo 26
Florence 22
Mumbai 20
Jacksonville 19
Medford 19
Shanghai 19
Moscow 17
Boardman 16
New York 16
Boston 12
Brussels 10
Izmir 9
Los Angeles 9
Luni 9
Milan 9
London 8
Norwalk 8
Kent 7
Abidjan 6
Dong Ket 6
Andover 5
Livorno 5
Washington 5
Falls Church 4
Ottawa 4
Phoenix 4
Toronto 4
Helsinki 3
Lappeenranta 3
Ponti sul Mincio 3
Rome 3
San Diego 3
Yubileyny 3
Barcelona 2
Campi Bisenzio 2
Chester 2
Duncan 2
Genoa 2
Hillsboro 2
Imola 2
Lambeth 2
Laurel 2
Milzano 2
Monopoli 2
Palermo 2
Parma 2
Pesaro 2
Riga 2
Salerno 2
Sommacampagna 2
Torre del Greco 2
Varese 2
Zurich 2
Acton 1
Ambrolauri 1
Bari 1
Bologna 1
Bremen 1
Bucharest 1
Castelliri 1
Cologne 1
Hanoi 1
Hanover 1
Islington 1
Kilburn 1
Kolkata 1
Leawood 1
Macclesfield 1
Miaoli 1
Napoli 1
New Bedfont 1
Old Bridge 1
Padova 1
Prescot 1
Redmond 1
Redwood City 1
Rignano 1
San Mateo 1
Shenzhen 1
Tappahannock 1
Toulouse 1
Verona 1
Totale 2.319
Salva come PNG Salva come JPEG
Nome #
Treatment with 8-OH-modified adenine (TLR7 ligand)-allergen conjugates decreases T helper type 2-oriented murine airway inflammation 274
A novel allergen-adjuvant conjugate suitable for specific immunotherapy of respiratory allergy 273
Dermatophagoides pteronyssinus group 2 allergen bound to 8-OH modified adenine reduces the Th2-mediated airway inflammation without inducing a Th17 response and autoimmunity 245
Efficacy and safety of mepolizumab (Anti-Interleukin-5) treatment in Gleich's syndrome 157
The TLR7 Ligand 9-Benzyl-2-Butoxy-8-Hydroxy Adenine Inhibits IL-17 Response by Eliciting IL-10 and IL-10-Inducing Cytokines. 156
Skin testing and infliximab-specific antibodies detection as a combined strategy for preventing infusion reaction. 145
Assays and strategies for immunogenicity assessment of biological agents. 127
Anti-infliximab IgE and non-IgE antibodies and induction of infusion-related severe anaphylactic reactions. 111
Manifestations of Antidrug Antibodies Response: Hypersensitivity and Infusion Reactions. 110
Drug-Specific Th2 Cells and IgE Antibodies in a Patient with Anaphylaxis to Rituximab 106
Modified adenine (9-benzyl-2-butoxy-8-hydroxyadenine) redirects Th2-mediated murine lung inflammation by triggering TLR7. 105
The percentage of patients achieving complete remission of urticaria increases with repeated courses of treatment 101
High proportion of inflammatory CD62Llow eosinophils in blood and nasal polyps of severe asthma patients 98
Modified adenine (9-benzyl-2-butoxy-8-hydroxyadenine) redirects Th2-mediated murine lung inflammation by triggering TLR7. 95
A novel nDer p2-conjugated TLR7 down-modulates Th2-associated lung inflammation by using a therapeutical protocol 90
Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study 89
Low-dose mepolizumab effectiveness in patients suffering from eosinophilic granulomatosis with polyangiitis 85
A modified adenine chemically coupled to allergen molecole redirects allergen-specific Th2 cells 79
Hydroxy-adenines as in vivo and in vitro immunomodulators of allergic responses 76
Allergological in vitro and in vivo evaluation of patients with hypersensitivity reactions to infliximab. 73
Circulating T cells to infliximab are detectable mainly in treated patients developing anti-drug antibodies and hypersensitivity reactions 71
Etanercept inhibits the TNF-α driven shifting of Th17 towards non-classic Th1 phenotype in juvenile idiopathic arthritis. 70
Short and long-term effect of a novel nDer p2-conjugated TLR7 ligand in the prevention of allergic lung inflammation 68
The Kinetics of Antidrug Antibodies, Drug Levels, and Clinical Outcomes in Infliximab-Exposed Patients with Immune-Mediated Disorders 66
A novel antigen-conjugated TLR7 ligand regulates the lung inflammation and Th2-mediated response in a murine model of asthma 62
The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in desensitization to carboplatin in patients with ovarian cancer 61
Immunogenicity of Biological Agents: Basic Knowledge and Clinical Implications 58
Long-term retention rate of mepolizumab treatment in severe asthma: a 36-months real-life experience 48
Drug-specific Treg cells are induced during desensitization procedure for rituximab and tocilizumab in patients with anaphylaxis 46
Modified (2-Butoxy-8-Hydroxy-9-Benzyl) adenine redirects type 2 murine lung inflammation by triggering TLR7 in dendritic cells 42
Comparison of ELISA with automated ECLIA for IL-6 determination in COVID-19 patients: An Italian real-life experience 31
Dietary Antioxidants and Natural Compounds in Preventing Thrombosis and Cardiovascular Disease 17
Post-translational modifications of fibrinogen: implications for clotting, fibrin structure and degradation 16
null 14
Totale 3.265
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.148
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.148
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020351 0 0 0 0 57 52 49 58 46 43 42 4
2020/2021283 36 23 8 42 14 43 11 19 26 26 20 15
2021/2022200 4 16 16 5 8 11 7 19 7 11 45 51
2022/2023589 48 124 29 34 40 95 73 36 81 5 13 11
2023/2024291 15 23 32 24 34 38 21 58 6 11 10 19
2024/2025939 64 169 102 262 342 0 0 0 0 0 0 0
Totale 3.265